Patents Assigned to Arch Development Corporation
  • Patent number: 6436945
    Abstract: The present invention provides AGT inactivating compounds, for example, substituted O6-benzyl-8-aza-guanines of the formula wherein R, for example, is pivaloyloxymethyl as well as pharmaceutical compositions comprising such compounds along with a pharmaceutically acceptable carrier. The present invention further provides a method of enhancing the chemotherapeutic treatment of tumor cells in a mammal with an antineoplastic alkylating agent which causes cytotoxic lesions at the O6-position of guanine, by administering to a mammal an effective amount of one of the aforesaid compounds, and administering to the mammal an effective amount of an antineoplastic alkylating agent which causes cytotoxic lesions at the O6-position of guanine.
    Type: Grant
    Filed: August 14, 2001
    Date of Patent: August 20, 2002
    Assignees: The United States of America as represented by the of Health and Human Services, The Penn State Research Foundation, Arch Development Corporation
    Inventors: Robert C. Moschel, Anthony E. Pegg, M. Eileen Dolan, Mi-Young Chae
  • Patent number: 6429359
    Abstract: A genetic construct encoding a fusion protein including endogluconase E1 and a transit peptide is used to transform plants. The plants produce cellulase by expressing the genetic construct. The cellulase is targeted to plastids and can be collected and purified.
    Type: Grant
    Filed: September 2, 1999
    Date of Patent: August 6, 2002
    Assignee: ARCH Development Corporation
    Inventor: Gayle Lamppa
  • Patent number: 6426351
    Abstract: Chelerythrine is an effective inhibitor of solid tumor growth and is extremely cytotoxic in combination with chemotherapeutic agents that directly damage DNA.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: July 30, 2002
    Assignees: Dana-Farber Cancer, Inc., Arch Development Corporation
    Inventors: Ralph R. Weichselbaum, Donald W. Kufe, Steven J. Chmura, Mary E. Dolan
  • Patent number: 6420335
    Abstract: The present invention relates generally to the fields of angiogenesis and cancer therapy. More particularly, it concerns the use of anti-angiogenic factors in cancer therapy. The present invention demonstrates that angiostatin or endostatin can sensitize a cell to radiation therapy. Methods and compositions for inhibiting growth, sensitizing a cell to radiotherapy and treating cancer growth by first inhibiting angiogenesis and then employing radiotherapy are described.
    Type: Grant
    Filed: June 16, 1999
    Date of Patent: July 16, 2002
    Assignees: Dana Farber Cancer Institute, Inc., ARCH Development Corporation, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Ralph R. Weichselbaum, Vikas P. Sukhatme, Donald W. Kufe
  • Patent number: 6410704
    Abstract: The present invention relates to the identification and purification of a herpes protease and a nucleic acid segment coding for two proteins. The first protein is the herpes protease which is able to cleave itself and also cleave the second protein. This protease is required for the assembly of the herpes virus capsid, therefore is essential for replication. The second protein has previously been designated as the family of proteins in viral infected cells, ICP35. The protease and its substrates are encoded by overlapping nucleic acid segments. This invention also relates to a promoter sequence for the second protein. Methods are presented of producing a viral protease, screening a protease inhibitor which may be used in a drug designed for the treatment of herpes disease, methods for treating herpes and other viral infections wherein the virus employs a protease substantially similar to the herpes protease, for capsid production.
    Type: Grant
    Filed: January 3, 1994
    Date of Patent: June 25, 2002
    Assignee: Arch Development Corporation
    Inventors: Bernard Roizman, Fenyong Liu
  • Patent number: 6410923
    Abstract: Disclosed are lens apparatus in which a beam of charged particles is brought to a focus by means of a magnetic field, the lens being situated behind the target position. In illustrative embodiments, a lens apparatus is employed in a scanning electron microscope as the sole lens for high-resolution focusing of an electron beam, and in particular, an electron beam having an accelerating voltage of from about 10 to about 30,000 V. In one embodiment, the lens apparatus comprises an electrically-conducting coil arranged around the axis of the beam and a magnetic pole piece extending along the axis of the beam at least within the space surrounded by the coil. In other embodiments, the lens apparatus comprises a magnetic dipole or virtual magnetic monopole fabricated from a variety of materials, including permanent magnets, superconducting coils, and magnetizable spheres and needles contained within an energy-conducting coil.
    Type: Grant
    Filed: April 17, 2000
    Date of Patent: June 25, 2002
    Assignee: Arch Development Corporation
    Inventor: Albert V. Crewe
  • Patent number: 6405161
    Abstract: A method and system (200) provide automatic and unsupervised morphological analysis of a corpus of a natural language. An optimal division of each word in the corpus is determined (104) and identified stems and suffixes are combined as signatures (106). Major patterns of stem allomorphy are identified (110) and a morphological analysis is produced (112) for subsequent processing.
    Type: Grant
    Filed: July 26, 1999
    Date of Patent: June 11, 2002
    Assignee: Arch Development Corporation
    Inventor: John A. Goldsmith
  • Patent number: 6395510
    Abstract: The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant polypeptides. The invention further provides methods for using the isolated, recombinant polypeptides in assays designed to select and improve substances capable of altering programmed cell death for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: May 28, 2002
    Assignees: ARCH Development Corporation, Board of Regents of The University of Michigan
    Inventors: Craig B. Thompson, Lawrence H. Boise, Gabriel Nuñez
  • Patent number: 6383738
    Abstract: The present invention is directed to methods and compositions relating to the treatment of herpes simplex virus infections and the screening of compounds for activity that inhibit or promote viral latency. The previously identified ORF P gene product now has been shown to interact with certain eukaryotic splicing factors and, in a cell infected with a herpesvirus containing a derepressed ORF P gene, ORF P can limit the splicing of at least two viral products. Given this function, it now is possible to screen for inhibitors and inducers of ORF P and, further, provide methods for maintaining and preventing viral latency.
    Type: Grant
    Filed: December 7, 1998
    Date of Patent: May 7, 2002
    Assignee: Arch Development Corporation
    Inventors: Renato Bruni, Bernard Roizman
  • Patent number: 6363163
    Abstract: Method and system for the detection of interval change in medical images. Three dimensional images, such as previous and current section images in CT scans, are obtained. An anatomic feature, such as the lungs, is used to select sections containing lung by a gray-level thresholding technique. The section correspondence between the current and previous scans is determined automatically. The initial registration of the corresponding sections in the two scans is achieved by a rotation correction and a cross-correlation technique. A more accurate registration between the corresponding current and previous section images is achieved by local matching. A nonlinear warping process which is also based on the cross-correlation technique is applied to the previous image to yield a warped image after the matching. The final subtracted section images were derived by subtracting of the previous section images from the corresponding current section images.
    Type: Grant
    Filed: February 23, 1998
    Date of Patent: March 26, 2002
    Assignee: Arch Development Corporation
    Inventors: Xin-Wei Xu, Kunio Doi
  • Publication number: 20020021829
    Abstract: A method, system and computer readable medium for a computer-automated method for identifying given image data, including obtaining template image data corresponding to said given image data; calculating correlation values between the given image data and said template image data; and identifying said image data based on the correlation values calculated in the calculating step.
    Type: Application
    Filed: March 26, 2001
    Publication date: February 21, 2002
    Applicant: ARCH DEVELOPMENT CORPORATION
    Inventors: Kunio Doi, Hidetaka Arimura, Shigehiko Katsuragawa, Junji Morishita
  • Publication number: 20020019362
    Abstract: Disclosed are methods for treating cancer by administering an effective amount of a modified Herpes simplex virus.
    Type: Application
    Filed: September 26, 2001
    Publication date: February 14, 2002
    Applicant: Arch Development Corporation
    Inventors: Ralph Weichselbaum, Bernard Roizman, Richard J. Whitley
  • Publication number: 20020015944
    Abstract: The present invention provides the gene product of the herpes simplex virus UL13 gene as being capable of phosphorylating other gene products of the herpes simplex virus. The herpes simplex virus UL13 gene product is used in an assay to identify substances suspected of having anti-herpes simplex viral activity.
    Type: Application
    Filed: May 30, 2001
    Publication date: February 7, 2002
    Applicant: ARCH Development Corporation
    Inventors: Bernard Roizman, Frances C. Purves
  • Publication number: 20020009215
    Abstract: Automated Method and System for the Segmentation of Lung Regions in Computed Tomography Scans A method and system for the automated segmentation of the lung regions in thoracic CT scans includes construction of a cumulative gray level profile from pixels along the diagonal of each CT section image. The shape of this profile is used to identify a gray level threshold that is used to create a binary image. A contour detection algorithm generates a segmented thorax region. The trachea and main bronchi are segmented and eliminated from the segmented thorax region to prevent subsequent inclusion within the segmented lung regions. A gray level histogram is constructed to identify a second gray level threshold, which is applied to the segmented thorax region to create a binary image. If the two lungs regions are “fused,” the anterior junction is then delineated and turned “off” in the binary image to separate the two lungs.
    Type: Application
    Filed: January 17, 2001
    Publication date: January 24, 2002
    Applicant: ARCH DEVELOPMENT CORPORATION
    Inventors: Samuel G. Armato, Heber MacMahon, Maryellen L. Giger
  • Patent number: 6340673
    Abstract: The present invention relates to methods of treatment of programmed cell death (apoptosis) through the use of the HSV-1 gene &ggr;134.5 or the product of its expression, ICP34.5. The gene and its expression have been demonstrated to be required for HSV-1 neurovirulence, and in particular, to act as an inhibitor of neuronal programmed cell death which allows for viral replication. Use of the gene therapy, or the protein itself, can be expected to result in inhibition of programmed cell death in various neurodegenerative diseases. This invention also relates to novel vectors for gene therapy, including modified herpes virus. Methods are presented for conducting assays for substances capable of mimicing, potentiating or inhibiting the expression of &ggr;134.5 or the activity of ICP34.5. Also, methods are disclosed for the treatment of tumorogenic diseases, including cancer, and for treatment of herpes and other viral infections using inhibitors of &ggr;134.5 expression or ICP34.5 activity.
    Type: Grant
    Filed: April 1, 1999
    Date of Patent: January 22, 2002
    Assignee: Arch Development Corporation
    Inventors: Bernard Roizman, Joany Chou
  • Publication number: 20020006216
    Abstract: A method, system and computer readable medium for automated detection of lung nodules in computed tomography (CT) image scans, including generating two-dimensional segmented lung images by segmenting a plurality of two-dimensional CT image sections derived from the CT image scans; generating three-dimensional segmented lung volume images by combining the two-dimensional segmented lung images; determining three-dimensional lung nodule candidates from the three-dimensional segmented lung volume images, including, identifying structures within the three-dimensional segmented lung volume images that meet a volume criterion; deriving features from the lung nodule candidates; and detecting lung nodules by analyzing the features to eliminate false-positive nodule candidates from the nodule candidates.
    Type: Application
    Filed: January 16, 2001
    Publication date: January 17, 2002
    Applicant: ARCH DEVELOPMENT CORPORATION
    Inventors: Samuel G. Armato, Maryellen L. Giger, Heber Macmahon
  • Patent number: 6335980
    Abstract: A method and system for the automated segmentation of the lung regions in lateral chest radiographs. This is achieved according to the invention by providing an improved computerized, automated method for image segmentation based on gray-level threshold analysis. A unique method for identifying an approximate outer bounds on the extent of the lung fields in the image is performed to restrict the region further analyzed. An iterative global gray-level thresholding method is applied based on the features of a global gray-level histogram. Features of the regions in a binary image constructed at each iteration are identified and subjected to a modified analysis to exclude regions external to the lung field. The initial lung region contour that results from this global process is used to facilitate a novel adaptive local gray level thresholding method. Individual regions-of-interest (ROIs) are placed along the initial contour. The dimensions of the several ROIs are based upon the patient anatomy enclosed therein.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: January 1, 2002
    Assignee: Arch Development Corporation
    Inventors: Samuel G. Armato, III, Maryellen L. Giger, Heber Macmahon
  • Patent number: 6333331
    Abstract: The present invention provides AGT inactivating compounds such as substituted O6-benzylguanines of the formula 7- or 9-substituted 8-aza-O6-benzylguanines, 7,8-disubstituted O6-benzylguanines, 7,9-disubstituted O6-benzylguanines, 4(6)-substituted 2-amino-5-nitro-6(4)-benzyloxypyrimidines, and 4(6)-substituted 2-amino-5-nitroso-6(4)-benzyloxypyrimidines, as well as pharmaceutical compositions comprising such compounds along with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 15, 1999
    Date of Patent: December 25, 2001
    Assignees: The United States of America as represented by the Department of Health and Human Services, The Penn State Research Foundation, ARCH Development Corporation
    Inventors: Robert C. Moschel, Anthony E. Pegg, M. Eileen Dolan, Mi-Young Chae
  • Patent number: 6331527
    Abstract: Disclosed is a smooth muscle cell specific promoter, the SM22&agr; gene promoter as well as the murine cDNA and genomic SM22&agr; nucleic acid sequences. Also disclosed are methods of preventing restenosis following balloon angioplasty and methods of treating asthma based on inhibition of smooth muscle cell proliferation by expressing cell cycle control genes, or contraction inhibiting peptides in smooth muscle cells, under the control of the SM22&agr; promoter.
    Type: Grant
    Filed: November 1, 1999
    Date of Patent: December 18, 2001
    Assignee: Arch Development Corporation
    Inventors: Michael S. Parmacek, Julian Solway
  • Patent number: 6324242
    Abstract: A method and apparatus are provided for reconstructing a tomographic image from a halfscan fan-beam sinogram using the parallel beam reconstruction algorithms. The method includes the steps of weighting at least some elements of the halfscan fan-beam sinogram to forming a weighted fan-beam sinogram and expanding the weighted fan-beam sinogram into a Fourier series. The method further includes the steps of linearly interpolating at least some elements of the Fourier series to form a parallel beam sinogram of linearly interpolated data and reconstructing the image from the parallel beam sinogram using the parallel beam reconstruction algorithms.
    Type: Grant
    Filed: February 11, 2000
    Date of Patent: November 27, 2001
    Assignee: Arch Development Corporation
    Inventor: Xiaochuan Pan